# Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts

> **NCT00968396** · PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Multiple Myeloma

## Interventions

- **PROCEDURE:** Apheresis
- **PROCEDURE:** Stem Cell Transplantation
- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT00968396
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-02
- **Primary completion:** 2015-02
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968396, "Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00968396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*